Clinical Trial Update: The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU) [NA]

View source ↗

Summary

A completed clinical trial investigated whether supplemental docosahexaenoic acid (DHA) affects neurocognitive outcomes in teen and adult women with phenylketon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• Docosahexaenoic acid (DHA) (docosahexaenoic acid)

Snippet

Sponsor: Emory University | Conditions: Phenylketonuria | NA | Status: COMPLETED